Several brokerage firms have issued their latest recommendations for top companies across sectors, offering insights for investors looking to track potential market movers today.

Indus Towers
CLSA has maintained an “Outperform” rating on Indus Towers, setting a target price of Rs 520 per share. Citi has also reaffirmed its Buy rating, with a target of Rs 460 per share.

UBL (United Breweries Ltd)
Nuvama continues to recommend a Buy on UBL, with a target price of Rs 2,400 per share.

Ashok Leyland
Ashok Leyland is in focus with multiple brokerages giving positive guidance. Morgan Stanley maintains an Overweight rating with a target of Rs 144 per share. Citi and Nomura both reiterate Buy ratings, targeting Rs 150 and Rs 144 per share, respectively.

M&M Financial Services
Citi maintains a Buy rating on M&M Financial, targeting Rs 292 per share.

Glenmark Pharmaceuticals
HSBC continues to support Glenmark with a Buy recommendation and a target price of Rs 2,380 per share.

Adani Power
InCred has maintained an Add rating on Adani Power, targeting Rs 649 per share.

Metal Sector Outlook
Citi notes that as market conditions tighten, spreads are expected to improve, potentially increasing profitability for Indian metal and mining companies. CLSA reports that China’s “anti-involution” plan will reduce steel capacity by 50 million tons in 2025, cutting production by 8.5% for the rest of the year. CLSA prefers JSPL for its strong capacity addition and continues to favour aluminium producers, highlighting Hindalco and Vedanta.

Telecom Sector Outlook
CLSA projects that rising ARPU for Jio will drive significant revenue growth, estimating a 50–60% increase in revenue and EBITDA reaching between US$11 billion and US$19 billion by FY28.

Insurance Sector Outlook
HSBC highlights that even without input tax credits, health insurance premiums could decline by around 7–15%, improving affordability and boosting demand.

ITC
Jefferies has reiterated its Buy recommendation on ITC, setting a target price of Rs 535 per share.

Disclaimer: This article is based on brokerage recommendations and is for informational purposes only. It is not investment advice.

TOPICS: Adani Power Glenmark Pharma Indus Towers ITC